Claim 70% Off TipRanks This Holiday Season
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Syra Health Corp. Class A ( (SYRA) ) just unveiled an update.
On August 13, 2025, Syra Health Corp. appointed Radhika Mereddy to its Board of Directors. Ms. Mereddy’s compensation will align with that of other non-employee directors, and there are no special arrangements or related party transactions influencing her appointment, despite her being a principal stockholder in several companies.
Spark’s Take on SYRA Stock
According to Spark, TipRanks’ AI Analyst, SYRA is a Neutral.
Syra Health’s overall score is primarily impacted by financial challenges, weak technical indicators, and a negative valuation perspective. While the earnings call highlighted some operational improvements, significant risks remain due to delisting, revenue declines, and federal funding uncertainties.
To see Spark’s full report on SYRA stock, click here.
More about Syra Health Corp. Class A
Average Trading Volume: 23,419
Technical Sentiment Signal: Sell
Current Market Cap: $937.2K
Learn more about SYRA stock on TipRanks’ Stock Analysis page.